Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Wacker Biotech announced a strategic collaboration with RNAV8 Bio, a pioneer in mRNA engineering for the development of ...

on the smaller size – ranging from hundreds of millions to single figure billions. As often when unproven technologies are getting established, it is the smaller biotechs that are pushing mRNA ...

Particularly in the Chinese local market, with a remarkably low vaccination rate of 0.1% and an expected market size of RMB 20 billion, this vaccine is likely to fill the gap in the mRNA technology ...

Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics.

Cellular factors that regulate the delivery and stability of mRNA vaccines in the body were revealed, proposing a new paradigm for mRNA therapeutics Date: April 3, 2025 Source: Institute for Basic ...

So instead of the one-size-fits-all approach taken with the widespread usage of mRNA COVID jabs, these new cancer vaccines must be personalized for each individual patient. The process is painstaking ...

RNA therapeutics market is expanding, driven by advancements in gene therapy, personalized medicine, and RNA-based drug delivery, along with rising research in mRNA vaccines, antisense ...

So instead of the one-size-fits-all approach taken with the widespread usage of mRNA COVID jabs, these new cancer vaccines must be personalized for each individual patient. The process is ...